About
Technology
Issues
FAQ
Links
Official Page
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.